FdaApplication

ANDA 215661

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALEMBIC PHARMACEUTICALS LTD
application_typeANDA
approval_date2023-08-24

Products (2)

ProductActive ingredientStrengthDosage form
ERYTHROMYCINERYTHROMYCIN250MGTABLET;ORAL
ERYTHROMYCINERYTHROMYCIN500MGTABLET;ORAL

2 products